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http://dx.doi.org/10.1016/j.bgm.201
2214-0247/Copyright ª 2015, TaiwanAbstract Radiotherapy is still an essential option for treatment of various stages of cancer.
However, the irradiation administered would deplete the hematopoietic stem cells in the bone
marrow, which would eventually decrease the number of lymphocytes and erythrocytes in the
circulatory system. EMSA eritin is a polyherbal formulation that has the ability to stimulate
erythropoiesis in mice after radiation therapy. Erythropoiesis is a complex mechanism
involving the interaction of dozens of genes that may also be involved in other cellular process,
such as lymphopoiesis. In this study, we elucidated the potential of EMSA eritin to stimulate
other mechanisms, in addition to being an inducer of erythrocyte production. Bioinformatic
analysis results indicated that the EMSA eritin formulation contains multiactive compounds
that synergistically drive hematopoiesis and trigger lymphocyte differentiation. We then
tested this prediction using an in vivo cell-culture system in a mice model. Experimental re-
sults suggested that EMSA eritin is able to induce hematopoietic stem cell proliferation and
differentiate these cells into lymphocytes in BALB/c mice after sublethal radiation therapy.
Moreover, the polyherbal formulation increased proliferation and survival of B and T lympho-
cytes in a dose-dependent manner. The results indicate that the polyherbal formulation is
adequate to ameliorate both erythropoiesis and lymphopoiesis. The formulation thus appearsof Biomedicine, Faculty of Medicine, University of Brawijaya, Jalan Veteran, Malang, Jawa Timur
oo.com (M. Ibrahim).
5.05.001
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Hematopoietic stem cell proliferation by EMSA eritin 111very promising for treatment of patients following radiation therapy. However, this warrants
further investigation.
Copyright ª 2015, Taiwan Genomic Medicine and Biomarker Society. Published by Elsevier
Taiwan LLC. All rights reserved.Introduction
Anemia can be caused by several factors such as renal
chronic diseases1e3 and irradiation in cancer patients.
However, radiotherapy is still an essential treatment for
patients with cancer.4,5 Cancer-related anemia is mostly
treated by administering erythropoietin.6 However, eryth-
ropoietin administration could potentially accelerate tumor
growth and jeopardize the survival of these patients.7 The
EMSA eritin is a polyherbal formulation that adequately
stimulates the production of erythrocytes in mice after
radiation therapy. The formulation thus looks promising for
use in safe anemia therapy.8
Erythropoiesis is a complex mechanism that occurs
through the activation of the Janus kinase/signal trans-
ducer and activator of transcription (JAK/STAT) signaling
pathway9 and Notch signaling.10 The JAK/STAT signaling
pathway activation is associated with the interaction of
dozen of genes that might also be associated with other
cellular processes, including cell proliferation, migration,
immunity, and hematopoiesis.11 The EMSA eritin formula-
tion has been proven to stimulate erythropoiesis by tar-
geting several genes that are involved in various other
pathways. Therefore, using bioinformatics tools,
we explored the potential of EMSA eritin to induce
other cellular mechanisms that are beneficial for human
health.
Bioinformatics has been used in various applications,
including for identifying toxicity of herbs,12 proteinepro-
tein interaction,13 and for understanding complex mech-
anisms of action of herbal formulations.14 EMSA eritin is a
multicomponent formulation and thus has multiple tar-
gets. The potency of these polyherbal formulations for
various purposes can be analyzed using biosystems based
on the interaction of the target gene with the active
compound in these formulations.15 Several studies have
been successfully using bioinformatic approach to under-
stand the mechanism of action of polyherbal products
[e.g., Chinese medicines,16 Indian medicine (Ayurveda),
Japanese medicine (Kampo), Korean medicine, and Ti-
betan medicine14]. In this study, using bioinformatics, we
demonstrate a novel function of EMSA eritin formulation in
the hematopoiesis pathwaydas an “inducer” of erythro-
cyte production.
Materials and methods
EMSA eritin formulation
Soybean, coconut and red rice were purchased on October
2013 from local market at Makasar, south of Sulawesi,
Indonesia.Soybean and red rice were washed and dried in a vacuum
oven at 40C, and then mashed to obtain particles of 60-
mesh size (250 mm). The powder was extracted using water
at a ratio of 1:10 (materials:water) for 2 hours at 50C. The
extract and coconut water were evaporated by freeze
drying for 24 hours at 60C. Finally, the three materials
were mixed with coconut water powder to produce a pol-
yherbal medicine called “EMSA eritin.”
Analysis of lymphocyte proliferation in vitro
Lymphocytes were isolated from the spleen of mice that
were maintained in a pathogen-free chamber. The mice
were killed by cervical dislocation, and the spleen was
removed and washed two times with phosphate-buffered
saline (PBS) in a sterile Petri dish. The organs were pressed
clockwise using a sterile syringe, and the homogenates
were mixed with 10 mL PBS to isolate lymphocytes. The
cell suspense was centrifuged at 2500 rpm, at 10C for 5
minutes. The supernatant was discarded, but the pellets
formed were taken and resuspended in Roswell Park Me-
morial Institute-1640 medium supplemented with 2-
mercaptoetanol (final concentration, 50 mL), 10% fetal
bovine serum, 10 mL a-CD3 (supernatant), and lipopoly-
saccharide (10 ng/mL). The cells (1.5e2  106 cells/mL)
were cultured in 48-well plates and classified into four
groups based on formulation treatment: three groups were
treated with different concentrations of EMSA eritin
(0.025 mg/mL, 0.25 mg/mL, and 2.5 mg/mL), and one
group did not receive this formulation and served as the
control group. The cells were cultured in an incubator
(culture conditions, 5% CO2 atmosphere at 37
C) for 3
days. The cells were then harvested and stained with
50 mL of fluorescein isothiocyanate (FITC)-conjugated
antimouse CD4 (clone GK1.5), phycoerythrin (PE)-conju-
gated antimouse CD25 (clone PC61.5), PE-conjugated
antimouse CD8 (clone 53-6.7), and PE-conjugated anti-
mouse B220 (clone RA3-6B2) antibody. The cell numbers
were counted using a flow cytometer (FACSCalibur; BD
Biosciences, New Jersey, USA), and calculated using BD
CellQuest PRO software.
In vivo analysis of hematopoietic stem cell
differentiation
Regular BALB/c mice (8e9-week old) were divided into six
groups: five groups received sublethal total body irradiation
(600 rad) from an open-beam cobalt 60 gamma source and
one group served as the control. Ten hours later, the irra-
diated mice were force fed with EMSA eritin at doses of
0 mg/g body weight (BW), 1 mg/g BW, 3 mg/g BW, and
9 mg/g BW, respectively. The EMSA eritin was given once a
112 M. Ibrahim et al.day for 2 weeks. Peripheral blood was monitored every
other day by counting blood cells using a hemocytometer.
The mice were maintained in the pathogen-free facility of
the Department of Biology, Faculty of Mathematic and
Natural Sciences, Brawijaya University, Malang, Indonesia.
Two weeks after the treatment, the bone marrow cells
were isolated. The cell-surface molecules were stained
using FITC-conjugated antimouse CD34 (clone RAM34), PE/
Cy5-conjugated antimouse CD135 (clone A2F10), PerCP-
conjugated antimouse CD117 (clone 2B8). Data obtained
were analyzed by CellQuest and tested by statistical anal-
ysis (analysis of variance) with p < 0.05 considered
significant.
Bioinformatic analysis for identification of EMSA
eritin-targeted protein and its network
Bioinformatic analysis was carried out by mapping the
interaction of the target genes with the active compound in
the formulation using HitPick and the Search Tool for the
Retrieval of Interacting Genes/Proteins (STRING) data-
base.17 First, the active compound in coconut water, red
rice, and soybean were curated through references. The
Simplified Molecular-Input Line-Entry system structure of
the active compounds identified was drawn using PubChem
Sketcher V2.4 (https://pubchem.ncbi.nlm.nih.gov). The
structure was used to predict the molecular or proteinFigure 1 Interaction of EMSA eritin targeted genes. Active com
matopoiesis and erythropoiesis. The figure indicates that EMSA er
topoiesis and erythropoiesis. The network analysis was carried out
Proteins database according to experimental data, data retrievedtarget using HITPICK, which was developed by Monica
Campillos, PhD (Helmholtz Center Munich, Germany).
The protein targets were analyzed using the STRING
database (http://string-db.org/) based on their interaction
with another protein that plays a role in erythropoiesis and
hematopoiesis. Molecular interactions were predicted using
the STRING database, which contains experimental data
and predictions of more than 5 million proteins and 200
million protein interactions. Proteineprotein interactions
were identified using a filter-based pathway (Kyoto Ency-
clopedia Gene and Genome pathway) that has been vali-
dated previously.
Result
Results of bioinformatic analysis indicated that EMSA eritin
has 15 protein targets from 14 active compounds. Further
analysis using the STRING database showed that these
proteins interacted with each other to form a complex
network. Interestingly, the protein complex also interacted
with genes that play a crucial role in erythropoiesis and
hematopoiesis (Figure 1). The data obtained suggest that
the mixture of active compounds in EMSA eritin was able to
stimulate hematopoiesis, despite erythropoiesis activation.
Several target genes (NOS and ESR) are strongly responsible
for hematopoiesis and innate immune system
homeostasis.18,19pounds in EMSA eritin targeted genes that are involved in he-
itin is able to simultaneously and synergistically induce hema-
using the Search Tool for the Retrieval of Interacting Genes/
from databases, and text-mining prediction methods.26e30
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Figure 2 EMSA eritin promotes T- and B-cell proliferation and survival. Spleen cells (2 106) were obtained from 7-week-old
wild-type BALB/c mice and cultured in 48-well plates for 96 hours in a medium containing anti-CD3 supernatant (1.5%). EMSA eritin
at different concentrations (dose 1 = 0.025 mg/mL; dose 2 = 0.25 mg/mL; dose 3 = 2.5 mg/mL) was added as indicated in panels.
After culture, cells were subjected to cell-surface molecule staining with anti-B220, anti-CD4, anti-CD8, and anti-CD25 antibodies.
Control is a simple culture without the addition of EMSA eritin. The panels show the percentage of cells positively stained with anti-
B220, anti-CD4, anti-CD8, anti-CD25 antibodies. Data are presented as mean  standard deviation (nZ 5 mice in each group).
Hematopoietic stem cell proliferation by EMSA eritin 113The capacity of EMSA eritin to regulate the differentia-
tion, proliferation, and survival of lymphocytes was eluci-
dated in the cell-culture system. The polyherbal
formulation increased proliferation and survival of lym-
phocytes B220þ, CD4þ, CD8þ, and CD25þ (Figure 2). Pro-
liferation of lymphocytes was found to increase along with
the augmentation of the EMSA eritin doses in a dose-
dependent manner. The results indicate that EMSA eritin
is able to stimulate proliferation, differentiation, and sur-
vival of both B and T lymphocytes. Therefore, we specu-
lated that the EMSA eritin formulation has the potential to
induce lymphopoiesis. We next examined its potential to
induce hematopoietic stem cell differentiation in a mice
model.
Regular BALB/c mice were irradiated (600 rad) to deplete
hematopoietic stem cells in the bone marrow. The irradi-
ated mice were treated with EMSA eritin each day for 2
weeks. The polyherbal formulation increased the prolifera-
tion of hematopoietic progenitor cells (CD34þCD117þ) in
BALB/c mice after radiation. The cell-surface molecule
CD117 plays a role in triggering cell proliferation, differen-
tiation, and survival.20 Moreover, the formulation triggered
the differentiation of the stem cells into lymphopoiesis lin-
eages (CD34þCD135þ; Figure 3). CD135 is necessary for
development of lymphocytes (B and T cells), but not for thedevelopment of other blood cells (myeloid development).
These results prove that the EMSA eritin is able to stimulate
lymphopoiesis in BALB/c mice after radiation.Discussion
The results of this study indicate that the active compounds
in the EMSA eritin polyherbal formulation are able to
stimulate hematopoiesis, leading to differentiation of
lymphocyte. This is consistent with the results of in silico
analysis that the active compounds interact with genes
involved in hematopoiesis. The study result also corre-
sponds with a previous report indicating that coconut water
improves homeostasis.21 Moreover, the other components
of red rice presented higher phenolic contents that exhibit
antioxidant activities.22 Soybean is an excellent source of
dietary peptides that have beneficial effects on immune
function, brain function, and neurochemicals in humans.23
Experimental results also illustrate that the EMSA eritin
formulation can regulate homeostasis.
Indeed, the polyherbal formulation is able to better
recover depletion of bone marrow stem cells after radi-
ation therapy than erythropoietin. This can be attributed
to the multiactive compounds in the formulation that
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Figure 3 EMSA eritin increases bone marrow cell survival, proliferation, and differentiation. Sublethally irradiated (600 rad) mice
received an oral administration of different concentrations of EMSA eritin (dose 1 = 0.025 mg/mL; dose 2 = 0.25 mg/mL; dose 3 = 2.5
mg/mL) for 15 days as indicated or erythropoietin (EPO) injection (according to company protocol). Bone marrow cells (2 106)
were obtained from the treated mice, and then subjected to cell-surface staining with anti-CD34, anti-CD135, and anti-CD117
antibodies. Controls are regular-type mice without manipulation. (A) Panels showing the percentage of cells positively stained
with CD34 and CD117 (CD34þCD177þ). (B) Panels showing the percentage of cells positively stained with CD34 and CD135
(CD34þCD135þ) in the panels. Data are presented as mean  standard deviation (nZ 4 mice in each group).
114 M. Ibrahim et al.work in synergy to improve hematopoiesis in the bone
marrow. Moreover, the EMSA eritin formulation also trig-
gers lymphocyte differentiation, in addition to its po-
tential to act as an inducer of hematopoietic stem cell
proliferation and erythropoiesis. The polyherbal can be
attributed to the activation of multiple targets (genes) by
the polyherbal formulation, which in-turn interact with a
group of genes that are responsible for hematopoiesis and
erythropoiesis. We then assumed that this polyherbal
formulation is adequate to ameliorate both erythropoiesis
and lymphopoiesis. The formulation also works as an
immunomodulator, which is very beneficial to cure can-
cer. Thus, the EMSA eritin formulation has dual benefits
for cancer patients: upregulating erythrocyte production
and stimulation of the immune system to attack cancer
cells.Previous studies have demonstrated that herbs such as
ashwagandha24 and xiao-ban-xia25 contain complex mole-
cules that have better efficacy compared with a single iso-
lated active compound. The multitarget capability of herbs
may simultaneously and synergistically induce molecular
mechanisms in cells. Based on these reports, we believe that
EMSA eritin improves homeostasis systemically. However,
the effects of EMSA eritin demonstrated in this study war-
rant further investigation for its possible use as a stimulator
of hematopoiesis in humans in future clinical trials.Conclusion
EMSA eritin is adequate to stimulate hematopoiesis, which
eventually leads to lymphopoiesis. This ability is confirmed by
Hematopoietic stem cell proliferation by EMSA eritin 115the increasing numbers of CD34þCD135þ cells in BALB/c mice
following irradiation. Besides, EMSA eritin increased prolif-
eration and differentiation of lymphocytes. Our study results
indicate that EMSA eritin is a promising option for stimulating
hematopoiesis in cancer patients after radiotherapy.
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